Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119562) titled 'Analysis of the mutational landscape of uveal melanoma and exploration of the mechanism of action of targeted drugs' on Feb. 28.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The Second Affiliated Hospital of Harbin Medical University
Condition:
Uveal melanoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-24
Target Sample Size: Observation group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303214
Published by HT Digital Content Services with permission from Health Daily Diges...